Skip to main content
SpringerLink
Log in

Urgent need of novel biomarkers of acute dyspnea

  • EM - COMMENTARY
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mockel M, Searle J, Muller R et al (2013) Chief complaints in medical emergencies. Eur J Emerg Med 20:103–108. https://doi.org/10.1097/MEJ.0b013e328351e609

    Article  PubMed  Google Scholar 

  2. Kelly AM, Keijzers G, Klim S et al (2017) An observational study of dyspnea in emergency departments: The Asia, Australia, and New Zealand Dyspnea in Emergency Departments Study (AANZDEM). Acad Emerg Med 24:328–336. https://doi.org/10.1111/acem.13118

    Article  PubMed  Google Scholar 

  3. MacLeod M, Papi A, Contoli M et al (2021) Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact. Respirology 26:532–551. https://doi.org/10.1111/resp.14041

    Article  PubMed  Google Scholar 

  4. McDonagh TA, Metra M, Adamo M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42:3599–3726. https://doi.org/10.1093/eurheartj/ehab368

    Article  CAS  Google Scholar 

  5. Celli BR, Fabbri LM, Aaron SD et al (2021) An updated definition and severity classification of COPD exacerbations: The Rome Proposal. Am J Respir Crit Care Med (online early). https://doi.org/10.1164/rccm.202108-1819PP

    Article  Google Scholar 

  6. Mathioudakis AG, Janssens W, Sivapalan P et al (2020) Acute exacerbations of chronic obstructive pulmonary disease: In search of diagnostic biomarkers and treatable traits. Thorax 75:520–527. https://doi.org/10.1136/thoraxjnl-2019-214484

    Article  PubMed  Google Scholar 

  7. Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89–95. https://doi.org/10.1067/MCP.2001.113989

    Article  Google Scholar 

  8. Collet J-P, Thiele H, Barbato E et al (2021) 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 42:1289–1367. https://doi.org/10.1093/eurheartj/ehaa575

    Article  Google Scholar 

  9. Wessman T, Tofik R, Ruge T et al (2021) Associations between biomarkers of multimorbidity burden and mortality risk among patients with acute dyspnea. Intern Emerg Med. https://doi.org/10.1007/s11739-021-02825-6

    Article  PubMed  PubMed Central  Google Scholar 

  10. MacDonald MI, Osadnik CR, Bulfin L et al (2021) MULTI-PHACET: multidimensional clinical phenotyping of hospitalised acute COPD exacerbations. ERJ Open Research 7:00198–02021. https://doi.org/10.1183/23120541.00198-2021

    Article  PubMed  PubMed Central  Google Scholar 

  11. Wen Y-C, Chen L-K, Hsiao F-Y (2017) Predicting mortality and hospitalization of older adults by the multimorbidity frailty index. PLoS ONE 12:e0187825. https://doi.org/10.1371/JOURNAL.PONE.0187825

    Article  PubMed  PubMed Central  Google Scholar 

  12. Kastner M, Hayden L, Wong G et al (2019) Underlying mechanisms of complex interventions addressing the care of older adults with multimorbidity: a realist review. BMJ Open 9:e025009. https://doi.org/10.1136/bmjopen-2018-025009

    Article  PubMed  PubMed Central  Google Scholar 

  13. Brochard L, Slutsky A, Pesenti A (2016) Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. Am J Respir Crit Care Med 195:438–442. https://doi.org/10.1164/rccm.201605-1081CP

    Article  Google Scholar 

Download references

Acknowledgements

Editorial support was provided by David Young of Young Medical Communications and Consulting Ltd, which was funded by the Consorzio Futuro in Ricerca of Ferrara, Italy.

Author information

Authors and Affiliations

  1. Section of Respiratory Diseases, Department of Medicine and Surgery, University of Modena and Reggio Emilia, Policlinico Di Modena, Largo del Pozzo 71, 41124, Modena, Italy

    Bianca Beghé, Enrico Clini & Leonardo M. Fabbri

  2. Section of Respiratory Medicine, Translational Medicine and for Romagna, University of Ferrara, Ferrara, Italy

    Leonardo M. Fabbri

Authors
  1. Bianca Beghé
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Enrico Clini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leonardo M. Fabbri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bianca Beghé.

Ethics declarations

Conflict of interest

BB reports receipt of lecture fees from Chiesi, AstraZeneca, and GlaxoSmithKline. All were outside the scope of this manuscript. EC reports receipt of honoraria for advisory boards or speaking events from Chiesi Farmaceutici, Astra-Zeneca, Guidotti-Malesci, Menarini Group, GlaxoSmithKline, Boehringer-Ingelheim, and Novartis. Institutional academic research was partly supported with research funding by Chiesi Farmaceutici and GlaxoSmithKline. All were outside the scope of this manuscript. LMF received consulting fees from Chiesi Farmaceutici, payment or honoraria for advisory boards or speaking events from Chiesi Farmaceutici, AstraZeneca, GlaxoSmithKline, Alfasigma, Novartis, and Verona Pharma, reimbursement of travel expenses from Chiesi Farmaceutici, Novartis, and Menarini, and participated in a data safety monitoring board or advisory board with Novartis and Chiesi. All were outside the scope of this manuscript.

Ethics approval

Not applicable.

Clinical Trial Registration

Not applicable.

Informed consent

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Beghé, B., Clini, E. & Fabbri, L.M. Urgent need of novel biomarkers of acute dyspnea. Intern Emerg Med 17, 491–493 (2022). https://doi.org/10.1007/s11739-021-02874-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-021-02874-x

Search

Navigation